Product Program year 2023 Source: CMS Open Payments

Yutiq

Drug Ophthalmology

NDC 71879-136-01

Open in the dashboard

General payments

$31,307

517 payments

Research payments

$82,105

17 payments

Through program year 2023, $31,307 in general payments and $82,105 in research payments were reported against Yutiq (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2023 General $31,307 517
2023 Research $82,105 17

Breakdown

Who paid General payments · program year 2023
  1. Alimera Sciences, Inc. $31,307 517 payments
Top recipients General payments · program year 2023
  1. Scott Westhouse Ophthalmology · Grand Rapids, MI $858 3% · 3 payments
  2. Sachin Mehta Ophthalmology · Phoenix, AZ $803 3% · 3 payments
  3. Christopher Singh Ophthalmology · Grand Blanc, MI $773 2% · 2 payments
  4. Mark Barakat Ophthalmology · Scottsdale, AZ $743 2% · 4 payments
  5. Rima Patel Retina Specialist · Phoenix, AZ $597 2% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Ophthalmology $18,915 60% · 230 practitioners
  2. Retina Specialist Ophthalmology $11,389 36% · 158 practitioners
  3. Uveitis and Ocular Inflammatory Disease Ophthalmology $491 2% · 7 practitioners
  4. Optometrist $370 1% · 17 practitioners
  5. Internal Medicine $142 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Arizona $4,736 15% · 19 recipients
  2. Michigan $3,639 12% · 16 recipients
  3. Florida $3,307 11% · 41 recipients
  4. Ohio $3,291 11% · 44 recipients
  5. California $3,201 10% · 49 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

517 general · 17 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record